Genalyte Releases High-Speed Covid-19 Antibody Test
Genalyte currently has the capacity to test 250,000 patients per month; the company is scaling up to test more than 7,500,000 patients per month by September.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
Genalyte currently has the capacity to test 250,000 patients per month; the company is scaling up to test more than 7,500,000 patients per month by September.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
In the United States, the digital pathology software will support the need for remote pathology brought about by the covid-19 pandemic.
Read MorePosted by | May 6, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The goal is to inform the medical community about the existence of immunity to covid-19 in healthcare settings and eventually the population at large.
Read MorePosted by | May 6, 2020 | Covid 19, Digital Pathology, Emerging & Zoonotic Diseases, Infectious Diseases, Mounting Systems & Substrates |
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
Read MorePosted by | May 6, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases, Printers, Swabs |
The quickest-to-produce swabs consist of a single plastic material from tip to tip, with a lattice or a honey dipper design to collect a sample at one end.
Read More